|
Platinum chemotherapy (cisplatin or carboplatin) Clinical Trials
1 actively recruiting trial across 1 location
Pipeline
Phase 1: 1
Top Sponsors
- TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)1
Indications
- KRAS G12S1
- Metastatic Non-Small Lung Cell Cancer1
- Advanced Lung Carcinoma1
- KRAS G12A1
- KRAS G12V1
Los Angeles, California1 trial
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
The Angeles Clinic and Research Institute - West Los Angeles Office
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.